Factors predicting ventilator dependence in patients with ventilator-associated pneumonia.
Impact of clinical severity index, infective pathogens and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia.
Higher levels of soluble Fas ligand and transforming growth factor-β after omalizumab treatment: A case report.
Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia.
First- or second-line gefitinib therapy in unknown epidermal growth factor receptor mutants of non-small-cell lung cancer patients treated in Taiwan.
